Skip to content

Peony and licorice decoction fumigation treatment for strephenopodia after stroke: study protocol for a randomized controlled pilot trial

The clinical effect and biomechanical mechanisms of Peony and licorice decoction fumigation treatment for poststroke strephenopodia: a randomized controlled pilot trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032433
Enrollment
Unknown
Registered
2020-04-28
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poststroke strephenopodia

Interventions

Sponsors

Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. confirmed stroke patients with results from computed tomography (CT) or magnetic resonance imaging (MRI); 2. aged between 35 and 75 years, male or female; 3. first episode of stroke or with a history of stroke but with no serious neurofunctional disablility and modified Ranking Scale (mRS) grade =24; 8. never used fumigation treatment before; 9. the patients or their legal guardian sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. received surgery or thrombolytic therapy; 2. duration of stroke more than 6 months; 3. stroke without strephenopodia or with but could not walk 6 meters; 4. vital signs are not stable or with worsening conditions such like new infarction or bleeding; 5. combined with other cerebral diseases such as subarachnoid hemorrhage, cerebral hemorrhage, brain tumor, brain trauma and so on; 6. combined with lumbar vertebrae disease, knee joint disease, foot disease and other diseases that can affect the patient's walking gait; 7. combined with severe dysfunction of heart, lung, liver, kidney and blood system; 8. combined with moderate to severe cognitive comprehension or visual impairment that can affet rehabilitation treatment or gait examination; 9. pregnant or lactating women; 10. participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Medial planter area;

Secondary

MeasureTime frame
Berg Balance Scale;Fugl-Meyer Assessment;Modified Ashworth Scale;Barthel Index;Stroke-Specific Quality of Life Scale;

Countries

China

Contacts

Public ContactJuanjuan Ai

Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine

15010179928@163.com+86 15010179928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026